Hap Trading, LLC Next Cure, Inc. Transaction History
Hap Trading, LLC
- $1.06 Trillion
- Q2 2025
A detailed history of Hap Trading, LLC transactions in Next Cure, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 11,800 shares of NXTC stock, worth $101,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,800Holding current value
$101,244% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NXTC
# of Institutions
26Shares Held
8.88MCall Options Held
0Put Options Held
0-
Sofinnova Investments, Inc. Menlo Park, CA2.67MShares$22.9 Million0.08% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.3MShares$19.8 Million0.18% of portfolio
-
Black Rock Inc. New York, NY761KShares$6.53 Million0.0% of portfolio
-
Cable Car Capital LLC San Francisco, CA758KShares$6.5 Million0.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny501KShares$4.3 Million0.0% of portfolio
About NextCure, Inc.
- Ticker NXTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,748,800
- Market Cap $238M
- Description
- NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...